When it comes to Covid-19 vaccines, Pfizer (PFE) and Moderna (MRNA) get all the headlines. To an extent, that makes sense. After all, both Pfizer’s Comirnaty Covid vaccine and Moderna’s
When it comes to Covid-19 vaccines, Pfizer (PFE) and Moderna (MRNA) get all the headlines. To an extent, that makes sense. After all, both Pfizer’s Comirnaty Covid vaccine and Moderna’s
Novavax (NVAX) shares have been volatile recently. News the EUA filing with the FDA for its Covid-19 vaccine NVX-CoV2373 has been further delayed – the company only submitted data concerning
In what looks like an extreme case of “sell the news,” shares of Gritstone bio (GRTS) cratered by 42% in Tuesday’s session following the release of positive trial data. Results
Compared to peers in the vaccine space, Inovio Pharmaceuticals’ (INO) DNA-based platform is somewhat unique. It could potentially boast the same hallmarks as mRNA vaccines – such as rapid modification,
The coronavirus pandemic has provided a boost – pardon the pun – for the vaccine market. The need to blunt Covid-19’s impact has resulted in a huge inflow of capital